Lindbrook Capital LLC Grows Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Lindbrook Capital LLC boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 52.6% in the fourth quarter, Holdings Channel.com reports. The firm owned 2,141 shares of the company’s stock after acquiring an additional 738 shares during the quarter. Lindbrook Capital LLC’s holdings in GE HealthCare Technologies were worth $166,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Cerity Partners LLC grew its stake in GE HealthCare Technologies by 27.2% during the fourth quarter. Cerity Partners LLC now owns 45,929 shares of the company’s stock worth $3,551,000 after buying an additional 9,809 shares during the period. Fifth Third Bancorp grew its stake in GE HealthCare Technologies by 3.9% during the fourth quarter. Fifth Third Bancorp now owns 33,632 shares of the company’s stock worth $2,600,000 after buying an additional 1,250 shares during the period. Douglas Lane & Associates LLC grew its stake in GE HealthCare Technologies by 22.1% during the fourth quarter. Douglas Lane & Associates LLC now owns 436,253 shares of the company’s stock worth $33,731,000 after buying an additional 79,073 shares during the period. John G Ullman & Associates Inc. grew its stake in GE HealthCare Technologies by 93.1% during the fourth quarter. John G Ullman & Associates Inc. now owns 57,916 shares of the company’s stock worth $4,478,000 after buying an additional 27,931 shares during the period. Finally, Prio Wealth Limited Partnership lifted its position in shares of GE HealthCare Technologies by 25.1% during the fourth quarter. Prio Wealth Limited Partnership now owns 215,317 shares of the company’s stock worth $16,648,000 after purchasing an additional 43,189 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on GEHC shares. Morgan Stanley boosted their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a research report on Monday, February 12th. Evercore ISI boosted their target price on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Argus boosted their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research report on Monday, April 1st. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and boosted their target price for the stock from $66.00 to $88.00 in a research report on Monday, February 12th. Finally, Citigroup upped their price target on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $95.09.

GE HealthCare Technologies Stock Up 2.3 %

Shares of NASDAQ:GEHC opened at $86.24 on Wednesday. The stock has a market capitalization of $39.35 billion, a price-to-earnings ratio of 28.56, a price-to-earnings-growth ratio of 2.93 and a beta of 0.94. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50. The company’s fifty day moving average is $88.84 and its two-hundred day moving average is $78.21. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. The company had revenue of $5.20 billion for the quarter, compared to analysts’ expectations of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The firm’s revenue was up 5.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.31 earnings per share. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a dividend of $0.03 per share. The ex-dividend date is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.97%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.